Theranostics · 2020 · 131 citations · 42 references
PharmacyImmunologyPharmaceuticsNanotechnologyRheumatologyTheranosticsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignRheumatoid ArthritisTheranostic NanoparticlesImmune Suppression MechanismsNanoparticle Imaging AgentsNanoparticle-based ImmunotherapyTargeted DeliveryTargeted Delivery SystemsTheranostic NanomaterialsTheranostic NanomedicineTheranostic Platforms
The inflammation-targeting, inherent contrast and therapeutic activity of this new albumin-cerium oxide nanoparticle may make it a relevant agent for assessing severity in RA, and other inflammatory diseases, and controlling inflammation with image-guidance. The design of these nanotheranostics will enable potential clinical translation as systemic therapy for RA.
42
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh et al. · Arthritis & Rheumatism · 2005 · 1.8K citations
David Brand, Kary A. Latham, Edward F. Rosloniec · Nature Protocols · 2007 · 1.4K citations
The role of cerium redox state in the SOD mimetic activity of nanoceria
Eric Heckert, Ajay Karakoti, Sudipta Seal et al. · Biomaterials · 2008 · 998 citations · Full text